Everyoneiswaitingforsomedecentnewstodropthatisall..thentheSPcanmove...amatteroftime(fullfinanceapproval,dealannornextquarterlytoshowontrackforbreakeven)UntilthenfearanduncertaintyrulestheSP.In FY18 Lifx had operating expenses of approximately $3.7m per qtr. In the June qtr 2019, Lifx appear to have had operating expenses of approximately $5.0m.
Peoplewillassessanddetermineifworththeriskisworththereward.Orwaituntilafterthenextdecentannouncementtoreassess.Couldwellbe31stOctattheearliest.
ItpurelycomesdowntopersonalrisklevelsandunderstandingwherethisbusinessisatanddoyoutrustthecompanytojustkeeprunningLIFXasithasbeenrunning-forward.
In the June qtr 2019, the first qtr under BUD's ownership, Lifx appears to have had their largest quarterly loss.
In my opinion BUD needs to cut expenses across the whole business, which is something they have not been good at previously.
Having to raise cash so soon after the last raising does not make me feel confident of a good September quarter.
- Forums
- ASX - By Stock
- BUD
- Ann: Share Purchase Plan
Ann: Share Purchase Plan, page-26
-
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online